Table 2.
Treatment and glycemic control in the diabetic patient population (N = 186)
| Characteristic | Patients % (n/N) |
|---|---|
| Metformin | |
| Yes | 59.7 (111/186) |
| No | 40.3 (75/186) |
| Glibenclamide | |
| Yes | 32.3 (60/186) |
| No | 67.7 (126/186) |
| Insulin | |
| Yes | 11.3 (21/186) |
| No | 88.7 (165/186) |
| Other antidiabetic medication | |
| Yes | 5.4 (10/186) |
| No | 94.6 (176/186) |
| Basal Fasting Glucose | |
| Mean (± S.D.) | 170 (78.5) |
| Range | 74–604 |
| Glycemic Control (n = 185)a | |
| Proper (<130 mg/dLb) | 31.2 (58/185) |
| Improper (≥130 mg/dLb) | 68.8 (127/185) |
a One patient with missing glucose values
b Calculated mean serum glucose